The beauty of this is there will now be mulitple revenue streams for ResappDx and management said the consumer side will not interfere with the hospital uses.
RAP effectively has potential multiple revenue streams from ResappDX and also from Sleep Apnea...
- Forums
- ASX - By Stock
- RAP
- Ann: 2019 Letter to Shareholders
Ann: 2019 Letter to Shareholders, page-23
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)